vs
Side-by-side financial comparison of Aterian, Inc. (ATER) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $15.1M, roughly 1.4× Aterian, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -84.4%, a 31.9% gap on every dollar of revenue. On growth, Aterian, Inc. posted the faster year-over-year revenue change (-38.5% vs -65.2%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -13.5%).
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
ATER vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.1M | $20.6M |
| Net Profit | $-7.9M | $-17.3M |
| Gross Margin | 56.1% | — |
| Operating Margin | -51.1% | -106.0% |
| Net Margin | -52.5% | -84.4% |
| Revenue YoY | -38.5% | -65.2% |
| Net Profit YoY | -512.2% | -173.8% |
| EPS (diluted) | — | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.1M | — | ||
| Q3 25 | $19.0M | — | ||
| Q2 25 | $19.5M | — | ||
| Q1 25 | $15.4M | $20.6M | ||
| Q4 24 | $24.6M | $37.4M | ||
| Q3 24 | $26.2M | $19.6M | ||
| Q2 24 | $28.0M | $94.7M | ||
| Q1 24 | $20.2M | $59.1M |
| Q4 25 | $-7.9M | — | ||
| Q3 25 | $-2.3M | — | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-3.9M | $-17.3M | ||
| Q4 24 | $-1.3M | $1.1M | ||
| Q3 24 | $-1.8M | $-14.0M | ||
| Q2 24 | $-3.6M | $55.0M | ||
| Q1 24 | $-5.2M | $23.5M |
| Q4 25 | 56.1% | — | ||
| Q3 25 | 56.1% | — | ||
| Q2 25 | 54.3% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 63.4% | — | ||
| Q3 24 | 60.3% | — | ||
| Q2 24 | 60.4% | — | ||
| Q1 24 | 65.1% | — |
| Q4 25 | -51.1% | — | ||
| Q3 25 | -10.7% | — | ||
| Q2 25 | -23.1% | — | ||
| Q1 25 | -24.1% | -106.0% | ||
| Q4 24 | -6.5% | -15.7% | ||
| Q3 24 | -6.6% | -110.7% | ||
| Q2 24 | -11.5% | 56.4% | ||
| Q1 24 | -26.1% | 35.7% |
| Q4 25 | -52.5% | — | ||
| Q3 25 | -12.0% | — | ||
| Q2 25 | -25.0% | — | ||
| Q1 25 | -25.4% | -84.4% | ||
| Q4 24 | -5.3% | 3.0% | ||
| Q3 24 | -6.8% | -71.7% | ||
| Q2 24 | -13.0% | 58.1% | ||
| Q1 24 | -25.5% | 39.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-0.42 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $1.55 | ||
| Q1 24 | — | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.2M | $417.3M |
| Total Assets | $29.6M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $10.5M | — | ||
| Q1 25 | $14.3M | $67.8M | ||
| Q4 24 | $18.0M | $101.2M | ||
| Q3 24 | $16.1M | $78.0M | ||
| Q2 24 | $20.3M | $185.3M | ||
| Q1 24 | $17.5M | $68.4M |
| Q4 25 | $15.2M | — | ||
| Q3 25 | $22.6M | — | ||
| Q2 25 | $24.3M | — | ||
| Q1 25 | $27.0M | $417.3M | ||
| Q4 24 | $30.0M | $428.7M | ||
| Q3 24 | $30.6M | $422.4M | ||
| Q2 24 | $30.9M | $429.9M | ||
| Q1 24 | $33.0M | $269.4M |
| Q4 25 | $29.6M | — | ||
| Q3 25 | $40.1M | — | ||
| Q2 25 | $45.4M | — | ||
| Q1 25 | $49.8M | $486.5M | ||
| Q4 24 | $49.5M | $526.3M | ||
| Q3 24 | $52.1M | $554.6M | ||
| Q2 24 | $59.9M | $582.0M | ||
| Q1 24 | $55.7M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-38.5M |
| Free Cash FlowOCF − Capex | $-1.0M | $-39.7M |
| FCF MarginFCF / Revenue | -6.9% | -192.9% |
| Capex IntensityCapex / Revenue | 0.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-4.4M | — | ||
| Q1 25 | $-3.9M | $-38.5M | ||
| Q4 24 | $-9.0K | $-31.6M | ||
| Q3 24 | $-722.0K | $-24.3M | ||
| Q2 24 | $2.9M | $39.8M | ||
| Q1 24 | $-6.0K | $-25.5M |
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-4.4M | — | ||
| Q1 25 | — | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | $2.9M | $38.8M | ||
| Q1 24 | $-42.0K | $-26.4M |
| Q4 25 | -6.9% | — | ||
| Q3 25 | -8.4% | — | ||
| Q2 25 | -22.7% | — | ||
| Q1 25 | — | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | 10.3% | 41.0% | ||
| Q1 24 | -0.2% | -44.6% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 5.6% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 3.3% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.2% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
TRDA
Segment breakdown not available.
